Weekly Paclitaxel in the Treatment of Advanced or Metastatic Breast Cancer Previously Treated or Not Treated with Docetaxel: A Phase II Study

Publisher： Karger

E-ISSN： 1421-9794|51|2-3|126-131

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.2-3, 2005-06, pp. : 126-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-Dose Weekly Docetaxel Is as Tolerable as Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 147-155

Karger

Access to resources Recommend Favorite

A Phase II Study Directed by a Clinical Pathway for Carboplatin and Weekly Paclitaxel in Previously Untreated Patients with Unresectable Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 56, Iss. 1, 2010-02 ,pp. : 39-45

Karger

Access to resources Recommend Favorite

A Multicentre Phase II Study of Docetaxel plus Cisplatin for the Treatment of Advanced Gastric Cancer

By  

Chemotherapy, Vol. 53, Iss. 6, 2007-10 ,pp. : 454-460

Karger

Access to resources Recommend Favorite

Second-Line Combination Chemotherapy with Vinorelbine and Capecitabine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines and/or Taxanes

By  

Chemotherapy, Vol. 57, Iss. 1, 2011-02 ,pp. : 71-76

Karger

Access to resources Recommend Favorite

A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 58, Iss. 1, 2012-02 ,pp. : 78-83

Karger

Access to resources Recommend Favorite